The Relationship of Rhinitis and Asthma, Sinusitis, Food Allergy, and Eczema

Immunology and Allergy Clinics of North America

Volumn 31, Issue 3, 2011, Pages 481-491

  Tan, Ricardo A ^a   Corren, Jonathan ^b  

^a California Allergy and Asthma Medical Group   (United States)

^b Allergy Medical Clinic   (United States)

Author keywords

Asthma; Eczema; Food allergy; Rhinitis

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BECLOMETASONE; CETIRIZINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FILAGGRIN; FLUTICASONE PROPIONATE; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 5; LEUKOTRIENE; LEVOCETIRIZINE; METHACHOLINE; NITRIC OXIDE; PIMECROLIMUS; PLACEBO; PREDNISONE; PROBIOTIC AGENT; PROSTAGLANDIN; STEROID; THYMIC STROMAL LYMPHOPOIETIN; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE SINUSITIS; ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; ATOPY; AVOIDANCE BEHAVIOR; BACTERIAL SINUSITIS; BASOPHIL; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC SINUSITIS; CLINICAL FEATURE; CROSS LINKING; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; ECZEMA; FOOD ALLERGY; GENE MUTATION; HAY FEVER; HISTAMINE RELEASE; HOUSE DUST ALLERGY; HUMAN; HYPERSENSITIVITY REACTION; IMMUNOTHERAPY; MAST CELL; NASAL BIOPSY; NOSE CONGESTION; NOSE OBSTRUCTION; NOSE POLYP; NOSE PROVOCATION TEST; NOSE SECRETION; PARANASAL SINUS; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; POLLEN ALLERGY; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINUSITIS; SKIN BIOPSY; SKIN PRURITUS; SKIN TEST; TREATMENT DURATION; UPREGULATION;

ALLERGENS; ASTHMA; ECZEMA; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; RHINITIS; RISK FACTORS; SINUSITIS;

EID: 79960008036     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2011.05.010     Document Type: Review

References (71)

1. Greisner W.A., Settipane R.J., Settipane G.A. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 1998, 19(4):185-188.
2. Danielsson J., Jessen M. The natural course of allergic rhinitis during 12 years of follow-up. Allergy 1997, 52(3):331-334.
3. Guerra S., Sherrill D.L., Martinez F.D., et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002, 109(3):419-425.
4. Settipane R.J., Hagy G.W., Settipane G.A. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994, 15(1):21-25.
5. Linneberg A., Henrik Nielsen N., Frølund L., et al. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study. Allergy 2002, 57(11):1048-1052.
6. Leynaert B., Neukirch F., Demoly P., et al. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000, 106(5 Suppl):S201-S205.
7. Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108(5 Suppl):S147-S334.
8. Bousquet J., Khaltaev N., Cruz A.A., et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008, 63(Suppl 86):8-160.
9. Braunstahl G.J. The unified immune system: respiratory tract-nasobronchial interaction mechanisms in allergic airway disease. J Allergy Clin Immunol 2005, 115(1):142-148.
10. Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003, 111(6):1171-1183. [quiz: 1184].
11. Dixon A.E. Rhinosinusitis and asthma: the missing link. Curr Opin Pulm Med 2009, 15(1):19-24.
12. Fontanari P., Zattara-Hartmann M.C., Burnet H., et al. Nasal eupnoeic inhalation of cold, dry air increases airway resistance in asthmatic patients. Eur Respir J 1997, 10(10):2250-2254.
13. Braunstahl G.J., Overbeek S.E., Kleinjan A., et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001, 107(3):469-476.
14. Corren J., Adinoff A.D., Irvin C.G. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 1992, 89(2):611-618.
15. Littell N.T., Carlisle C.C., Millman R.P., et al. Changes in airway resistance following nasal provocation. Am Rev Respir Dis 1990, 141(3):580-583.
16. Schumacher M.J., Cota K.A., Taussig L.M. Pulmonary response to nasal-challenge testing of atopic subjects with stable asthma. J Allergy Clin Immunol 1986, 78(1 Pt 1):30-35.
17. Bardin P.G., Van Heerden B.B., Joubert J.R. Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis. J Allergy Clin Immunol 1990, 86(1):82-88.
18. Assanasen P., Baroody F.M., Naureckas E., et al. The nasal passage of subjects with asthma has a decreased ability to warm and humidify inspired air. Am J Respir Crit Care Med 2001, 164(9):1640-1646.
19. Bousquet J., Boushey H.A., Busse W.W., et al. Characteristics of patients with seasonal allergic rhinitis and concomitant asthma. Clin Exp Allergy 2004, 34(6):897-903.
20. Togias A.G. Systemic immunologic and inflammatory aspects of allergic rhinitis. J Allergy Clin Immunol 2000, 106(5 Suppl):S247-S250.
21. Dorman S.C., Sehmi R., Gauvreau G.M., et al. Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation. Am J Respir Crit Care Med 2004, 169(5):565-572.
22. Marcucci F., Passalacqua G., Canonica G.W., et al. Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon. Respir Med 2007, 101(7):1600-1608.
23. Braunstahl G.J., Overbeek S.E., Fokkens W.J., et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001, 164(5):858-865.
24. Corren J., Adinoff A.D., Buchmeier A.D., et al. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992, 90(2):250-256.
25. Watson W.T., Becker A.B., Simons F.E. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993, 91(1 Pt 1):97-101.
26. Foresi A., Pelucchi A., Gherson G., et al. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996, 98(2):274-282.
27. Polosa R., Li Gotti F., Mangano G., et al. Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis. Allergy 2004, 59(11):1224-1228.
28. Niggemann B., Jacobsen L., Dreborg S., et al. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy 2006, 61(7):855-859.
29. Crystal-Peters J., Neslusan C., Crown W.H., et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002, 109(1):57-62.
30. Bjermer L. Montelukast in the treatment of asthma as a systemic disease. Expert Rev Clin Immunol 2005, 1(3):325-336.
31. Dykewicz M.S., Hamilos D.L. Rhinitis and sinusitis. J Allergy Clin Immunol 2010, 125(2 Suppl 2):S103-S115.
32. Slavin R.G., Spector S.L., Bernstein I.L., et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005, 116(6 Suppl):S13-S47.
33. Schubert M.S., Goetz D.W. Evaluation and treatment of allergic fungal sinusitis. II. Treatment and follow-up. J Allergy Clin Immunol 1998, 102(3):395-402.
34. Schubert M.S., Goetz D.W. Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis. J Allergy Clin Immunol 1998, 102(3):387-394.
35. Berrettini S., Carabelli A., Sellari-Franceschini S., et al. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy 1999, 54(3):242-248.
36. Hamilos D.L., Leung D.Y., Wood R., et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995, 96(4):537-544.
37. al Ghamdi K., Ghaffar O., Small P., et al. IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment. J Otolaryngol 1997, 26(3):160-166.
38. Pant H., Ferguson B.J., Macardle P.J. The role of allergy in rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2009, 17(3):232-238.
39. Farabollini B., Braschi M.C., Bonifazi F. Allergic rhinitis and associated pathologies: the rationale for steroid options. Eur Ann Allergy Clin Immunol 2009, 41(3):67-79.
40. Venekamp R.P., Sachs A.P., Bonten M.J., et al. Intranasal corticosteroid monotherapy in acute rhinosinusitis: an evidence-based case report. Otolaryngol Head Neck Surg 2010, 142(6):783-788.
41. Mori F., Barni S., Pucci N., et al. Upper airways disease: role of corticosteroids. Int J Immunopathol Pharmacol 2010, 23(1 Suppl):61-66.
42. Kalish L.H., Arendts G., Sacks R., et al. Topical steroids in chronic rhinosinusitis without polyps: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2009, 141(6):674-683.
43. Leung D.Y., Boguniewicz M., Howell M.D., et al. New insights into atopic dermatitis. J Clin Invest 2004, 113(5):651-657.
44. Spergel J.M. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol 2010, 105(2):99-106. [quiz: 107-9, 117].
45. van der Hulst A.E., Klip H., Brand P.L. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol 2007, 120(3):565-569.
46. Kulig M., Bergmann R., Klettke U., et al. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999, 103(6):1173-1179.
47. Kapoor R., Menon C., Hoffstad O., et al. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol 2008, 58(1):68-73.
48. Gustafsson D., Sjoberg O., Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis-a prospective follow-up to 7 years of age. Allergy 2000, 55(3):240-245.
49. Cork M.J., Robinson D.A., Vasilopoulos Y., et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006, 118(1):3-21. [quiz: 22-3].
50. Baurecht H., Irvine A.D., Novak N., et al. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 2007, 120(6):1406-1412.
51. Smith F.J., Irvine A.D., Terron-Kwiatkowski A., et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006, 38(3):337-342.
52. Hanifin J.M. Evolving concepts of pathogenesis in atopic dermatitis and other eczemas. J Invest Dermatol 2009, 129(2):320-322.
53. Weidinger S., O'Sullivan M., Illig T., et al. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 2008, 121(5). 1203. e1-1209. e1.
54. Akei H.S., Brandt E.B., Mishra A., et al. Epicutaneous aeroallergen exposure induces systemic TH2 immunity that predisposes to allergic nasal responses. J Allergy Clin Immunol 2006, 118(1):62-69.
55. Spergel J.M., Mizoguchi E., Brewer J.P., et al. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998, 101(8):1614-1622.
56. He R., Oyoshi M.K., Jin H., et al. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc Natl Acad Sci U S A 2007, 104(40):15817-15822.
57. Demehri S., Morimoto M., Holtzman M.J., et al. Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS Biol 2009, 7(5):e1000067.
58. Barberio G., Pajno G.B., Vita D., et al. Does a 'reverse' atopic march exist?. Allergy 2008, 63(12):1630-1632.
59. Warner J.O. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol 2001, 108(6):929-937.
60. Simons F.E. Safety of levocetirizine treatment in young atopic children: an 18-month study. Pediatr Allergy Immunol 2007, 18(6):535-542.
61. del Giudice M.M., Rocco A., Capristo C. Probiotics in the atopic march: highlights and new insights. Dig Liver Dis 2006, 38(Suppl 2):S288-S290.
62. Lee J., Seto D., Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008, 121(1). 116.e11-21.e11.
63. Cingi C., Demirbas D., Songu M. Allergic rhinitis caused by food allergies. Eur Arch Otorhinolaryngol 2010, 267(9):1327-1335.
64. Branum A.M., Lukacs S.L. Food allergy among children in the United States. Pediatrics 2009, 124(6):1549-1555.
65. Eigenmann P.A., Sicherer S.H., Borkowski T.A., et al. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998, 101(3):E8.
66. Novembre E., de Martino M., Vierucci A. Foods and respiratory allergy. J Allergy Clin Immunol 1988, 81(5 Pt 2):1059-1065.
67. Penard-Morand C., Raherison C., Kopferschmitt C., et al. Prevalence of food allergy and its relationship to asthma and allergic rhinitis in schoolchildren. Allergy 2005, 60(9):1165-1171.
68. Sahin-Yilmaz A., Nocon C.C., Corey J.P. Immunoglobulin E-mediated food allergies among adults with allergic rhinitis. Otolaryngol Head Neck Surg 2010, 143(3):379-385.
69. Kusunoki T., Morimoto T., Nishikomori R., et al. Allergic status of schoolchildren with food allergy to eggs, milk or wheat in infancy. Pediatr Allergy Immunol 2009, 20(7):642-647.
70. Wallace D.V., Dykewicz M.S., Bernstein D.I., et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008, 122(2 Suppl):S1-S84.
71. Blumchen K., Ulbricht H., Staden U., et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010, 126(1). 83.e1-91.e1.